CIK: 0001388325 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value ($000): $1,025,645 (99.0% shares, 1.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $301,604 | 29.4% | $57.39 | — | TOTAL STK MKT | 922908769 |
| — | OPHTHOTECH CORP | 6,896,819 | $268,493 | 26.2% | $32.35 | — | COM | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $116,017 | 11.3% | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| INGN | INOGEN INC | 5,419,449 | $111,695 | 10.9% | $17.78 | +14.2% | COM | 45780L104 |
| — | OTONOMY INC | 2,175,025 | $52,201 | 5.1% | $24.00 | — | COM | 68906L105 |
| — | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | $40,591 | 4.0% | $20.07 | — | COM | 014339105 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,516,387 | $33,558 | 3.3% | $24.08 | -4.6% | COM | 00972D105 |
| — | FLEXION THERAPEUTICS INC | 1,783,131 | $32,560 | 3.2% | $16.45 | — | COM | 33938J106 |
| — | ZS PHARMA INC | 506,730 | $19,879 | 1.9% | $39.23 | — | COM | 98979G105 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $17,955 | 1.8% | $13.52 | — | COM | 88165N105 |
| — | TOKAI PHARMACEUTICALS INC | 1,075,037 | $15,519 | 1.5% | $14.44 | — | COM | 88907J107 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $10,148 | 1.0% | $2.50 | — | RIGHT 03/01/2019 | 98235T115 |
| — | INTERSECT ENT INC | 350,000 | $5,425 | 0.5% | $15.50 | — | COM | 46071F103 |